Advertisement
Canada markets close in 6 hours 18 minutes
  • S&P/TSX

    22,158.80
    +51.72 (+0.23%)
     
  • S&P 500

    5,251.97
    +3.48 (+0.07%)
     
  • DOW

    39,795.06
    +34.98 (+0.09%)
     
  • CAD/USD

    0.7372
    0.0000 (-0.00%)
     
  • CRUDE OIL

    82.58
    +1.23 (+1.51%)
     
  • Bitcoin CAD

    96,049.64
    +419.83 (+0.44%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,229.00
    +16.30 (+0.74%)
     
  • RUSSELL 2000

    2,114.35
    +44.19 (+2.13%)
     
  • 10-Yr Bond

    4.2200
    +0.0240 (+0.57%)
     
  • NASDAQ

    16,396.44
    -3.08 (-0.02%)
     
  • VOLATILITY

    12.95
    +0.17 (+1.33%)
     
  • FTSE

    7,956.44
    +24.46 (+0.31%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6817
    +0.0012 (+0.18%)
     

CLASS ACTION UPDATE for EH, FUBO and ATNX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / April 16, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

EH Shareholders Click Here: https://www.zlk.com/pslra-1/ehang-holdings-limited-loss-submission-form?prid=14790&wire=1
FUBO Shareholders Click Here: https://www.zlk.com/pslra-1/fubotv-inc-loss-submission-form?prid=14790&wire=1
ATNX Shareholders Click Here: https://www.zlk.com/pslra-1/athenex-inc-loss-submission-form?prid=14790&wire=1

* ADDITIONAL INFORMATION BELOW *

Ehang Holdings Limited (NASDAQ:EH)

EH Lawsuit on behalf of: investors who purchased December 12, 2019 - February 16, 2021
Lead Plaintiff Deadline : April 19, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/ehang-holdings-limited-loss-submission-form?prid=14790&wire=1

ADVERTISEMENT

According to the filed complaint, during the class period, Ehang Holdings Limited made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's purported regulatory approvals in Europe and North American for its EH216 were for use as a drone, and not for carrying passengers; (ii) its relationship with its purported primary customer is a sham; (iii) EHang has only collected on a fraction of its reported sales since its ADS began trading on NASDAQ in December 2019; (iv) the Company's manufacturing facilities were practically empty and lacked evidence of advanced manufacturing equipment or employees; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

fuboTV Inc. (NYSE:FUBO)

FUBO Lawsuit on behalf of: investors who purchased March 23, 2020 - January 4, 2021
Lead Plaintiff Deadline : April 19, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/fubotv-inc-loss-submission-form?prid=14790&wire=1

According to the filed complaint, during the class period, fuboTV Inc. made materially false and/or misleading statements and/or failed to disclose that: (ii) Fubo offering of products was subject to undisclosed cost escalations; (iii) Fubo could not successfully compete and perform as sports book operator and could not capitalize on its only sports wagering opportunity; (iv) Fubo's data and inventory was not differentiated to allow Fubo to achieve long-term advertising growth goals and forecasts; (v) Fubo's valuation was overstated in light of its total revenue and subscription levels; (vi) the acquisition of Balto Sport did not provide the stated synergies, internal expertise, and did not expand the Company's addressable market into online sports wagering; and as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Athenex, Inc. (NASDAQ:ATNX)

ATNX Lawsuit on behalf of: investors who purchased August 7, 2019 - February 26, 2021
Lead Plaintiff Deadline : May 3, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/athenex-inc-loss-submission-form?prid=14790&wire=1

According to the filed complaint, during the class period, Athenex, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the data included in the Oral Paclitaxel plus Encequidar NDA presented a safety risk to patients in terms of an increase in neutropenia-related sequalae; (ii) the uncertainty over the results of the primary endpoint of objective response rate (ORR) at week 19 conducted by BICR; (iii) the BICR reconciliation and re-read process may have introduced unmeasured bias and influence on the BICR; (iv) the Company's Phase 3 study that was used to file the NDA was inadequate and not well-conducted in a patient population with metastatic breast cancer representative of the U.S. population, such that the FDA would recommended a new such clinical trial; (v) as a result, it was foreseeable that the FDA would not approve the Company's NDA in its current form; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/640768/CLASS-ACTION-UPDATE-for-EH-FUBO-and-ATNX-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders